Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (696)	7/30/1998 5:13:00 PM
From: Bluegreen	Respond to of 3202

Great info. Rman. How come I learn the most from my "stupid" questions?

To: Rocketman who wrote (696)	7/31/1998 6:27:00 AM
From: Richard Huth	Read Replies (1) \| Respond to of 3202

Thank you for explaining what I have said with less words (and not that accurate - not ironically, I really appreciate your postings!). But there is some fear out in the market, and not everyone who is trading INCY is that good informed as you are. So this concern will have an impact, if you see it as BS or not. I have no real clue why shares have been under pressure that much. But coming back to the problem of taking future royalty streams into account today, we could find a reason in PER. If you don't look at these revenues - and here you are right,you cannot count them today - actual PER is quite high. With an expected EPS growth of 30% within the next 18 month and an PER of 38 (based on '99) INCY is priced fairly with not much room for big gains. Perhaps this might be a reason why some investors are selling and looking for "more interesting" stories in the market.